DM

Don McCaffrey

President & CEO

Resverlogix

Calgary, Alberta


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Resverlogix
Industry
biotechnology
Employees
22.0
Seniority
C suite
Annual Revenue
3221000.0

Technologies

EasyDNS DigitalOcean Typekit Google Analytics Google Font API YouTube Mobile Friendly Google Tag Manager

Keywords

cardiovascular disease atherosclerosis neurodegenerative diseases diabetes mellitus chronic kidney disease drug development epigenetics drug discovery muscular dystrophy biotechnology life sciences apabetalone epigenetic therapeutics clinical trials chronic illness bet proteins gene regulation breakthrough therapy designation health solutions covid-19 treatment pulmonary arterial hypertension phase 3 clinical trial high-risk patients clinical evaluation chronic disease management vascular disease therapeutic potential health payer groups pharmaceutical partnerships innovative drug therapies gene expression clinical research biosimilars therapeutics for diabetes high-density lipoprotein chronic conditions biologic drug research & development scientific strategy multinational trials disease-associated epigenetics treatment paradigm shift major adverse cardiac events life sciences innovation investigational new drug medical communications healthcare advancements value-based healthcare clinical development strategy biotech industry patient quality of life research publications patent applications cardiometabolic syndrome disease prevention strategies biopharmaceuticals health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans